IMCT-21UPDATES ON PHASE 1B/2 COMBINATION STUDY OF THE IDO PATHWAY IHIBITOR INDOXIMOD WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH TEMOZOLOMIDE-REFRACTORY PRIMARY MALIGNANT BRAIN TUMORS
Authors:
Open Access
- 9 November 2015
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 17 (suppl 5) , v112.2-v112